BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7342848)

  • 21. [Rheologic effects of normovolemic hemodilution].
    Kuznetsov NA; Aleksandrova NP; Bogdanov AE; Rogulenko RV
    Anesteziol Reanimatol; 1990; (2):18-22. PubMed ID: 1698041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isovolemic hemodilution: a therapeutical intervention for improving microcirculation.
    Rudofsky G
    Int Angiol; 1986; 5(3):151-4. PubMed ID: 3559316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Conservative therapy of peripheral arterial occlusive diseases].
    Alexander K
    Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C; Wehofer D; Weidinger P
    Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral vascular disease: flow studies and clinical results after isovolemic hemodilution--case reports.
    Caputi CA; De Carolis G
    Angiology; 1986 Feb; 37(2):124-7. PubMed ID: 3954151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematocrit as a risk factor for vascular disease.
    Kiesewetter H; Jung F; Lazar H; Roggenkamp HG; Leipnitz G; Kiehl R
    Klin Wochenschr; 1986 Oct; 64(19):974-8. PubMed ID: 3784450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
    Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
    Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
    [No Abstract]   [Full Text] [Related]  

  • 29. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
    Vigilance JE; Reid HL
    J Diabetes Complications; 2008; 22(3):210-6. PubMed ID: 18413225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease.
    Giunta R; Coppola A; Luongo C; Sammartino A; Guastafierro S; Grassia A; Giunta L; Mascolo L; Tirelli A; Coppola L
    Ann Hematol; 2001 Dec; 80(12):745-8. PubMed ID: 11797116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 32. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
    Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
    Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gelatin for volume replacement in hemodilution: hemodynamic study].
    Falchi S; Caresia C; Linden M; Vannucci F; Novelli GP
    Minerva Anestesiol; 1995; 61(7-8):299-305. PubMed ID: 8948741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic effects of prolonged normovolemic hemodilution in patients with Raynaud's disease].
    Mamurov VA
    Khirurgiia (Mosk); 1998; (12):22-3. PubMed ID: 9916428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diluted albumin-dextran 40 combination in treating arteriopathy of the lower extremities by normovolemic hemodilution. The rheological effects].
    Stoltz JF; Chevraud C; Voisin P; Burdin D; Streiff F; Laxenaire MC
    J Mal Vasc; 1986; 11(4):344-50. PubMed ID: 2433377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Arterial ulcers of the lower limbs].
    Lazareth I
    Soins; 2008; (722):46-50. PubMed ID: 18333347
    [No Abstract]   [Full Text] [Related]  

  • 40. [Distal obliterating arteriopathy of the lower limbs in a systemic disease. Treatment with normovolemic hemodilution. [Report of one case]].
    Ouvry P; Ouvry P; Guenneguez H; Duruble M
    J Mal Vasc; 1991; 16(4):387-9. PubMed ID: 1791377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.